@article{ref1,
title="An HIV-infected Patient with No Serious Adverse Events after Overdosing on Raltegravir",
journal="Internal medicine",
year="2020",
author="Hosoda, Tomohiro and Uehara, Yuki and Naito, Toshio",
volume="59",
number="2",
pages="285-287",
abstract="Patients with HIV infection represent a high-risk group for medication overdose because of the high frequency of complicating psychiatric disorders. Raltegravir is well-known for its low frequency of adverse effects. We herein report a 42-year-old Japanese man with HIV infection who was hospitalized 6 hours after overdosing with 24,000 mg of raltegravir in a suicide attempt. No serious adverse events occurred, although the plasma concentration of raltegravir at 18 hours after the overdose was 79,871.1 ng/mL. Raltegravir may be well-indicated for HIV patients at risk of overdosing.<p /><p>Language: en</p>",
language="en",
issn="0918-2918",
doi="10.2169/internalmedicine.3498-19",
url="http://dx.doi.org/10.2169/internalmedicine.3498-19"
}